Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Merck
Medtronic
Dow
McKesson

Last Updated: May 19, 2022

CLINICAL TRIALS PROFILE FOR TESTOSTERONE UNDECANOATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Testosterone Undecanoate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00117000 ↗ The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly Unknown status Organon Phase 3 2003-07-01 The purpose of this study is to determine what effect treatment for one year with testosterone and a nutritional supplement, alone and combined, has on the adverse effects of under-nutrition in community-dwelling older men and women.
NCT00117000 ↗ The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly Unknown status University of Adelaide Phase 3 2003-07-01 The purpose of this study is to determine what effect treatment for one year with testosterone and a nutritional supplement, alone and combined, has on the adverse effects of under-nutrition in community-dwelling older men and women.
NCT00119483 ↗ Older Men and Testosterone Completed University Hospital of North Norway N/A 2005-09-01 Male hypogonadism is a clinical situation characterized by a low serum testosterone level in combination with a diversity of symptoms and signs such as reduced libido and vitality, decreased muscle mass, increased fat mass and depression. Similar symptoms in combination with subnormal testosterone levels are seen in some elderly men. Low testosterone levels are associated with known cardiovascular risk factors, and men with diabetes and stroke have lower testosterone levels than healthy men. Even though several publications have suggested that testosterone treatment in hypogonadal men may have beneficial effects, it is still uncertain if testosterone substitution in the aging man is indicated. Despite this uncertainty the sale of testosterone has increased enormously the last few years. We hypothesize that older men with subnormal testosterone levels have a varying degree of dysfunction/symptoms both physically and mentally, and that these dysfunction/symptoms can be improved with testosterone treatment.
NCT00146146 ↗ Testosterone and Its Metabolites in GID Completed Schering-Plough Phase 3 2005-05-01 The purposes of this study are: - to determine the role of testosterone versus dihydrotestosterone with respect to the following physiological functions: bone metabolism, body composition, insulin resistance and lipid profile - to determine the role of testosterone and dihydrotestosterone versus estradiol with respect to the following physiological functions: bone metabolism, body composition, insulin resistance and lipid profile
NCT00146146 ↗ Testosterone and Its Metabolites in GID Completed Unita Complessa di Ostetricia e Ginecologia Phase 3 2005-05-01 The purposes of this study are: - to determine the role of testosterone versus dihydrotestosterone with respect to the following physiological functions: bone metabolism, body composition, insulin resistance and lipid profile - to determine the role of testosterone and dihydrotestosterone versus estradiol with respect to the following physiological functions: bone metabolism, body composition, insulin resistance and lipid profile
NCT00220298 ↗ Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism Completed Bayer Phase 3 2003-02-01 This study will evaluate the preparation of testosterone undecanoate under conditions which resemble real-life situations.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Testosterone Undecanoate

Condition Name

Condition Name for Testosterone Undecanoate
Intervention Trials
Hypogonadism 19
Hypogonadism, Male 10
Male Hypogonadism 8
Obesity 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Testosterone Undecanoate
Intervention Trials
Hypogonadism 37
Eunuchism 13
Diabetes Mellitus, Type 2 3
Erectile Dysfunction 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Testosterone Undecanoate

Trials by Country

Trials by Country for Testosterone Undecanoate
Location Trials
United States 99
Germany 12
Thailand 3
United Kingdom 3
Mexico 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Testosterone Undecanoate
Location Trials
California 11
Florida 9
Alabama 8
Texas 7
New York 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Testosterone Undecanoate

Clinical Trial Phase

Clinical Trial Phase for Testosterone Undecanoate
Clinical Trial Phase Trials
Phase 4 9
Phase 3 18
Phase 2/Phase 3 3
[disabled in preview] 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Testosterone Undecanoate
Clinical Trial Phase Trials
Completed 42
Unknown status 5
Recruiting 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Testosterone Undecanoate

Sponsor Name

Sponsor Name for Testosterone Undecanoate
Sponsor Trials
Clarus Therapeutics, Inc. 11
Bayer 5
Syneos Health 4
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Testosterone Undecanoate
Sponsor Trials
Other 71
Industry 41
NIH 4
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Mallinckrodt
Express Scripts
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.